ScholarIQanswers from OpenAlex & ORCID
John T. Poirier
ResearcherPublications, citations & collaboration network
John T. Poirier is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John T. Poirier have?
ScholarIQindexed works
John T. Poirier has 420 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John T. Poirier have?
ScholarIQcitation count
John T. Poirier has 17,313 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John T. Poirier?
ScholarIQh-index
John T. Poirier has an h-index of 59 in OpenAlex.
What is the i10-index of John T. Poirier?
ScholarIQi10-index
John T. Poirier has an i10-index of 97 in OpenAlex.
What is the ORCID of John T. Poirier?
ScholarIQorcid
The ORCID for John T. Poirier is on the source record.
What is the OpenAlex record for John T. Poirier?
ScholarIQopenalex
The OpenAlex for John T. Poirier is on the source record.
What are the most-cited papers on John T. Poirier?
ScholarIQmost cited works
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M. Rudin, John T. Poirier, Lauren A. Byers, Caroline Dive, Afshin Dowlati, Julie George, John V. Heymach, Jane E. Johnson, Jonathan M. Lehman, David MacPherson, Pierre P. Massion, John D. Minna, Trudy G. Oliver, Vito Quaranta, Julien Sage, Roman K. Thomas, Christopher R. Vakoc, Adi F. Gazdar
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Charles M. Rudin, Steffen Durinck, Eric Stawiski, John T. Poirier, Zora Modrušan, David S. Shames, Emily Anne Smith Bergbower, Yinghui Guan, James Shin, Joseph Guillory, Celina Sanchez Rivers, Catherine K. Foo, Deepali Bhatt, Jeremy Stinson, Florian Gnad, Peter M. Haverty, Robert Gentleman, Subhra Chaudhuri, Vasantharajan Janakiraman, Bijay S. Jaiswal, Chaitali Parikh, Wenlin Yuan, Zemin Zhang, Hartmut Koeppen, Thomas D. Wu, Howard M. Stern, Robert L. Yauch, Kenneth E. Huffman, Diego D’Ávila Paskulin, Peter B. Illei, Marileila Varella‐Garcia, Adi F. Gazdar, Frédéric J. de Sauvage, Richard Bourgon, John D. Minna, Malcolm V. Brock, Somasekar Seshagiri
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J. Niederst, Lecia V. Sequist, John T. Poirier, Craig H. Mermel, Elizabeth L. Lockerman, Angel R. Garcia, Ryohei Katayama, Carlotta Costa, Kenneth N. Ross, Teresa Morán, Emily Howe, Linnea Fulton, Hillary E. Mulvey, Lindsay A. Bernardo, Farhiya Mohamoud, Norikatsu Miyoshi, Paul A. VanderLaan, Daniel B. Costa, Pasi A. Jänne, Darrell R. Borger, Sridhar Ramaswamy, Toshi Shioda, A. John Iafrate, Gad Getz, Charles M. Rudin, Mari Mino–Kenudson, Jeffrey A. Engelman
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
Laura R. Saunders, Alexander J. Bankovich, Wade Anderson, Monette Aujay, Sheila Bheddah, KristenAnn Black, Radhika Desai, Paul A. Escarpe, Johannes Hampl, Amy Laysang, David Liu, Javier Lopez-Molina, Milly Milton, Albert Park, Marybeth A. Pysz, Hui Shao, Brian C. Slingerland, Michael Torgov, Samuel A. Williams, Orit Foord, Philip W. Howard, Jacek Jassem, A. Badzio, Piotr Czapiewski, David H. Harpole, Afshin Dowlati, Pierre P. Massion, William D. Travis, M. Catherine Pietanza, John T. Poirier, Charles M. Rudin, Robert Stull, Scott J. Dylla
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
Eric E. Gardner, Benjamin H. Lok, Valentina E. Schneeberger, Patrice Desmeules, Linde A. Miles, Paige K. Arnold, Ai Ni, Inna Khodos, Elisa de Stanchina, Thuyen Nguyen, Julien Sage, John E. Campbell, Scott Ribich, Natasha Rekhtman, Afshin Dowlati, Pierre P. Massion, Charles M. Rudin, John T. Poirier